Biochemical and Demographical Differences in Atypical vs. Typical Femoral Fractures: A 10-Year Experience Across Two Centers

Background: Atypical femoral fractures (AFFs) are rare but serious complications of antiresorptive therapy (ART), frequently misdiagnosed and managed inappropriately in acute care settings. Early recognition remains critical to avoid further harm.

• Publication year

  2025

• Venue

  International Journal of Endocrinology

• Publication date

  2025-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/ije/9376426PMID 41049358PMCID 12496139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abnormally low serum albumin levels are associated with abnormal bone mineral density and osteoporotic fractures: a retrospective studies

  2024cited by this paper
• Early‐onset dementia and risk of hip fracture and major osteoporotic fractures

  2024cited by this paper
• Clinical and Genetic Characteristics of Hypophosphatasia in Chinese Adults

  2023cited by this paper
• Atypical Femoral Fracture in Hypophosphatasia: A Systematic Review

  2023cited by this paper
• Examination of Risk Factors and Expression Patterns of Atypical Femoral Fractures Using the Japanese Adverse Drug Event Report Database: A Retrospective Pharmacovigilance Study

  2023cited by this paper
• Vitamin B12 as a novel risk biomarker of spinal fractures

  2022cited by this paper
• A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients

  2022influential reference
• Prevalence of Low Serum Alkaline Phosphatase and Hypophosphatasia in Adult Patients with Atypical Femur Fractures

  2022cited by this paper
• Bilateral atypical femoral fractures during denosumab therapy in a patient with adult-onset hypophosphatasia

  2021influential reference
• ALPL genotypes in patients with atypical femur fractures or other biochemical and clinical signs of hypophosphatasia.

  2021cited by this paper
• Biochemical, clinical and genetic characteristics in adults with persistent hypophosphatasaemia; Data from an endocrinological outpatient clinic in Denmark

  2021cited by this paper
• Tissue-Nonspecific Alkaline Phosphatase—A Gatekeeper of Physiological Conditions in Health and a Modulator of Biological Environments in Disease

  2020cited by this paper
• Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice

  2020cited by this paper
• Position Statement on the Use of Bone Turnover Markers for Osteoporosis Treatment

  2019cited by this paper
• Diaphyseal Femur Fracture

  2019cited by this paper
• Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia—not atypical at all

  2018cited by this paper
• Atypical Femoral Fracture: A Fascinating Story in Evolution

  2018cited by this paper
• Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives

  2017cited by this paper
• Hypophosphatasia — aetiology, nosology, pathogenesis, diagnosis and treatment

  2016cited by this paper
• Hypoalbuminemia and Osteoporosis: Reappraisal of a Controversy.

  2016cited by this paper
• The skeletal muscle cross sectional area in long-term bisphosphonate users is smaller than that of bone mineral density-matched controls with increased serum pentosidine concentrations.

  2015cited by this paper
• Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls.

  2013cited by this paper
• Atypical femoral fractures: epidemiology, etiology, and patient management

  2012cited by this paper
• Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects.

  2011cited by this paper
• Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

  2011cited by this paper
• Atypical femoral fractures and bisphosphonate use.

  2010cited by this paper
• Biomarkers of bone health and osteoporosis risk*

  2008cited by this paper
• Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.

  2007cited by this paper
• Relationship Between Serum Albumin and Bone Mineral Density in Postmenopausal Women and in Patients with Hypoalbuminemia

  1999cited by this paper

• Atypical Femur Fractures Without Bisphosphonate Exposure (AFFwB): A Retrospective Report of 21 Cases

  2025cites this paper